中医药调控JAK/STAT信号通路介导溃疡性结肠炎的研究进展
Progress of Chinese Medicine in Regulating JAK/STAT Signaling Pathway Mediating Ulcerative Colitis
摘要: 溃疡性结肠炎是一种难治性慢性非特异性炎症性肠病,严重影响患者身心健康及生活质量。中医治疗溃疡性结肠炎具有复发率低、不良反应少的优势,方药、穴位敷贴、艾灸等都有较好的临床疗效。本文将从分子生物学的角度阐述中医药对溃疡性结肠炎的作用机制。JAK/STAT信号通路与炎症反应具有密切关系,激活后引起肠黏膜屏障损伤。近年来应用中医药调控JAK/STAT信号通路治疗溃疡性结肠炎成为研究热点。本文就中医药通过调控JAK/STAT信号通路治疗溃疡性结肠炎做一综述,为有效用药及药物研发提供依据。
Abstract: Ulcerative colitis is a refractory chronic non-specific inflammatory bowel disease, which seriously affects the physical and mental health and quality of life of patients. Traditional Chinese medicine (TCM) treatment of ulcerative colitis has the advantages of low recurrence rate and fewer adverse reactions, and prescription medicines, acupoints, moxibustion, etc. have better clinical efficacy. In this paper, we will elaborate the mechanism of TCM on ulcerative colitis from the perspective of molecular biology. JAK/STAT signaling pathway has a close relationship with inflammatory response, and its activation causes intestinal mucosal barrier damage. The activation of JAK/STAT signaling pathway is closely related to the inflammatory response, causing damage to the intestinal mucosal barrier. In this paper, we review the use of traditional Chinese medicine in the treatment of ulcerative colitis by regulating the JAK/STAT signaling pathway, which will provide a basis for the effective use of medication and drug development.
文章引用:代月盈, 姜德友. 中医药调控JAK/STAT信号通路介导溃疡性结肠炎的研究进展[J]. 临床医学进展, 2024, 14(5): 1230-1235. https://doi.org/10.12677/acm.2024.1451545

参考文献

[1] Le, B.C., Honap, S. and Peyrin-Biroulet, L. (2023) Ulcerative Colitis. The Lancet, 402, 571-584. [Google Scholar] [CrossRef
[2] Shapiro, J.M., Zoega, H., Shah, S.A., et al. (2016) Incidence of Crohn’s Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn’s and Colitis Area Registry. Inflammatory Bowel Diseases, 22, 1456-1461. [Google Scholar] [CrossRef
[3] O’Shea, J.J., Schwartz, D.M., Villarino, A.V., et al. (2015) The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention. Annual Review of Medicine, 66, 311-328. [Google Scholar] [CrossRef] [PubMed]
[4] Din, S., Selinger, C.P., Black, C.J., et al. (2023) Systematic Review with Network Meta-Analysis: Risk of Herpes Zoster with Biological Therapies and Small Molecules in Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics, 57, 666-675. [Google Scholar] [CrossRef] [PubMed]
[5] Xiu, M.X., Liu, Y.M., Chen, G.Y., et al. (2021) Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis. Digestive Diseases and Sciences, 66, 3002-3014. [Google Scholar] [CrossRef] [PubMed]
[6] Long, Y., Xia, C.S., Zeng, X., et al. (2023) Altered Phenotypes of Colonic and Peripheral Blood Follicular Helper and Follicular Cytotoxic T Cells in Mice with DSS-Induced Colitis. Journal of Inflammation Research, 16, 2879-2892. [Google Scholar] [CrossRef
[7] Li, H.X., Zhao, W., Shi, Y., et al. (2015) Retinoic Acid Amide Inhibits JAK/STAT Pathway in Lung Cancer Which Leads to Apoptosis. Tumor Biology, 36, 8671-8678. [Google Scholar] [CrossRef] [PubMed]
[8] Xin, P., Xu, X., Deng, C., et al. (2020) The Role of JAK/STAT Signaling Pathway and Its Inhibitors in Diseases. International Immunopharmacology, 80, Article 106210. [Google Scholar] [CrossRef] [PubMed]
[9] 卢世文, 余丽菲. JAK/STAT信号通路在小鼠心肌梗死发病中的作用及对NF-κB、TNF-α表达的影响[J]. 中国免疫学杂志, 2022, 38(5): 536-540.
[10] Zhu, F., He, H., Fan, L., et al. (2020) Blockade of CXCR2 Suppresses Proinflammatory Activities of Neutrophils in Ulcerative Colitis. American Journal of Translational Research, 12, 5237-5251.
[11] Wan, Z.K., Zhou, Z.F., Liu, Y., et al. (2020) Regulatory T Cells and T Helper 17 Cells in Viral Infection. Scandinavian Journal of Immunology, 91, e12873. [Google Scholar] [CrossRef] [PubMed]
[12] Cordes, F., Foell, D., Ding, J.N., et al. (2020) Differential Regulation of JAK/STAT-Signaling in Patients with Ulcerative Colitis and Crohn’s Disease. World Journal of Gastroenterology, 26, 4055-4075. [Google Scholar] [CrossRef] [PubMed]
[13] Soendergaard, C., Bergenheim, F.H., Bjerrum, J.T., et al. (2018) Targeting JAK-STAT Signal Transduction in IBD. Pharmacology & Therapeutics, 192, 100-111. [Google Scholar] [CrossRef] [PubMed]
[14] Troncone, E., Marafini, I., Del Vecchio Blanco, G., et al. (2020) Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors. Clinical and Experimental Gastroenterology, 13, 131-139. [Google Scholar] [CrossRef
[15] 安明伟, 王艳茹, 汤卢伟, 等. 葛根芩连汤对溃疡性结肠炎大鼠IL-6/JAK/STAT信号通路的影响[J]. 时珍国医国药, 2021, 32(9): 2081-2084.
[16] 吴云翔, 陈光华, 陈教华, 等. 加减地榆汤通过调控SOCS2/3表达影响JAK2和STAT6的磷酸化治疗溃疡性结肠炎的作用机制[J]. 中药材, 2020, 43(12): 3035-3039.
[17] 吴甜甜, 刘雪珂, 刘馥春, 等. 左金丸对DSS诱导的溃疡性结肠炎小鼠免疫记忆性T细胞水平的调节作用[J]. 中药新药与临床药理, 2020, 31(10): 1158-1164.
[18] 纪佳, 陈岩岩. 黄芩汤对溃疡性结肠炎大鼠IL-6、JAKSTAT3信号通路及HMGB-1表达的影响[J]. 中医学报, 2018, 33(7): 1297-1301.
[19] 李春霖, 李时超, 贾英田, 等. 基于JAK/STAT信号通路探究黄连素对溃疡性结肠炎小鼠结肠皮细胞凋亡作用[J]. 中国药理学通报, 2023, 39(5): 938-945.
[20] Li, H., Feng, C.L., Fan, C., et al. (2020) Intervention of Oncostatin M-Driven Mucosal Inflammation by Berberine Exerts Therapeutic Property in Chronic Ulcerative Colitis. Cell Death & Disease, 11, Article No. 271. [Google Scholar] [CrossRef] [PubMed]
[21] 马杰, 陈韵之, 田蕾. 黄芩多糖通过调节JAK2/STAT3通路和IL-23/IL-17炎性轴改善DSS诱导的UC模型小鼠的炎症[J]. 中山大学学报(医学科学版), 2023, 44(3): 423-429.
[22] 鲁慧东, 李艳梅. 白术内酯III通过调节JAK2/STAT3信号通路减轻溃疡性结肠炎模型小鼠肠道损伤[J]. 中国病理生理杂志, 2023, 39(1): 142-149.
[23] 许话, 严红梅, 陈斓. 仙茅苷对溃疡性结肠炎大鼠JAK/STAT/NF-κB信号通路的影响[J]. 中国药师, 2022, 25(3): 406-413.
[24] 陈凯, 朱莹. 基于JAK-STAT信号通路的溃结宁膏对HT-29细胞炎症模型的影响[J]. 中国中医药信息杂志, 2023, 30(2): 112-117.
[25] 王钰嘉, 于千惠, 卢雨微, 等. 穴位埋线联合艾灸对溃疡性结肠炎大鼠结肠组织IL-6/JAK/STAT3信号通路的影响[J]. 针刺研究, 2022, 47(6): 525-530.